Literature DB >> 93988

Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck.

S Davis, W Kessler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 93988     DOI： 10.1007/bf00254421

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  3 in total

1.  CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck.

Authors:  R E Wittes; E Cvitkovic; J Shah; F P Gerold; E W Strong
Journal:  Cancer Treat Rep       Date:  1977 May-Jun

Review 2.  The integration of chemotherapy into a combined modality approached to cancer therapy. V. Squamous cell cancer of the head and neck.

Authors:  M A Goldsmith; S K Carter
Journal:  Cancer Treat Rev       Date:  1975-06       Impact factor: 12.111

3.  Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy.

Authors:  V L Randolph; A Vallejo; R H Spiro; J Shah; E W Strong; A G Huvos; R E Wittes
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860
  3 in total
  3 in total

1.  Update in cancer chemotherapy: head and neck cancer, Part 2.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-11       Impact factor: 1.798

2.  Chemotherapy of solid tumours: trials and tribulations.

Authors:  G M Mead; J M Whitehouse
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-25

Review 3.  Chemotherapeutic management of head and neck cancer.

Authors:  M Al-Sarraf
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.